334 related articles for article (PubMed ID: 32966484)
1. Inhibitory activities of marine sulfated polysaccharides against SARS-CoV-2.
Song S; Peng H; Wang Q; Liu Z; Dong X; Wen C; Ai C; Zhang Y; Wang Z; Zhu B
Food Funct; 2020 Sep; 11(9):7415-7420. PubMed ID: 32966484
[TBL] [Abstract][Full Text] [Related]
2. Marine sulfated polysaccharides as potential antiviral drug candidates to treat Corona Virus disease (COVID-19).
Andrew M; Jayaraman G
Carbohydr Res; 2021 Jul; 505():108326. PubMed ID: 34015720
[TBL] [Abstract][Full Text] [Related]
3. Effective Inhibition of SARS-CoV-2 Entry by Heparin and Enoxaparin Derivatives.
Tandon R; Sharp JS; Zhang F; Pomin VH; Ashpole NM; Mitra D; McCandless MG; Jin W; Liu H; Sharma P; Linhardt RJ
J Virol; 2021 Jan; 95(3):. PubMed ID: 33173010
[TBL] [Abstract][Full Text] [Related]
4. Antiviral activity against dengue virus of diverse classes of algal sulfated polysaccharides.
Pujol CA; Ray S; Ray B; Damonte EB
Int J Biol Macromol; 2012 Nov; 51(4):412-6. PubMed ID: 22652218
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of SARS-CoV-2 Virus Entry by the Crude Polysaccharides of Seaweeds and Abalone Viscera In Vitro.
Yim SK; Kim K; Kim IH; Chun SH; Oh TH; Kim JU; Kim JW; Jung WH; Moon HS; Ku BS; Jung KJ
Mar Drugs; 2021 Apr; 19(4):. PubMed ID: 33921174
[TBL] [Abstract][Full Text] [Related]
6. Antiviral activity of marine sulfated glycans against pathogenic human coronaviruses.
Zoepfl M; Dwivedi R; Kim SB; McVoy MA; Pomin VH
Sci Rep; 2023 Mar; 13(1):4804. PubMed ID: 36959228
[TBL] [Abstract][Full Text] [Related]
7. Marine Sulfated Polysaccharides as Promising Antiviral Agents: A Comprehensive Report and Modeling Study Focusing on SARS CoV-2.
Salih AEM; Thissera B; Yaseen M; Hassane ASI; El-Seedi HR; Sayed AM; Rateb ME
Mar Drugs; 2021 Jul; 19(8):. PubMed ID: 34436245
[TBL] [Abstract][Full Text] [Related]
8. Potential Anti-COVID-19 Therapeutics that Block the Early Stage of the Viral Life Cycle: Structures, Mechanisms, and Clinical Trials.
Al-Horani RA; Kar S; Aliter KF
Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32718020
[TBL] [Abstract][Full Text] [Related]
9. The structure-activity relationship of the interactions of SARS-CoV-2 spike glycoproteins with glucuronomannan and sulfated galactofucan from Saccharina japonica.
Jin W; Zhang W; Mitra D; McCandless MG; Sharma P; Tandon R; Zhang F; Linhardt RJ
Int J Biol Macromol; 2020 Nov; 163():1649-1658. PubMed ID: 32979436
[TBL] [Abstract][Full Text] [Related]
10. Marine sulfated glycans inhibit the interaction of heparin with S-protein of SARS-CoV-2 Omicron XBB variant.
He P; Song Y; Jin W; Li Y; Xia K; Kim SB; Dwivedi R; Farrag M; Bates J; Pomin VH; Wang C; Linhardt RJ; Dordick JS; Zhang F
Glycoconj J; 2024 Apr; 41(2):163-174. PubMed ID: 38642280
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic Applications of Fucoidans and their Potential to Act Against COVID-19.
Yadav D; Song M
Curr Pharm Des; 2022; 28(46):3671-3676. PubMed ID: 36475344
[TBL] [Abstract][Full Text] [Related]
12. Antiviral Strategies Using Natural Source-Derived Sulfated Polysaccharides in the Light of the COVID-19 Pandemic and Major Human Pathogenic Viruses.
Ray B; Ali I; Jana S; Mukherjee S; Pal S; Ray S; Schütz M; Marschall M
Viruses; 2021 Dec; 14(1):. PubMed ID: 35062238
[TBL] [Abstract][Full Text] [Related]
13. The Potential of Algal Biotechnology to Produce Antiviral Compounds and Biopharmaceuticals.
Rosales-Mendoza S; García-Silva I; González-Ortega O; Sandoval-Vargas JM; Malla A; Vimolmangkang S
Molecules; 2020 Sep; 25(18):. PubMed ID: 32899754
[TBL] [Abstract][Full Text] [Related]
14. Structural and functional properties of SARS-CoV-2 spike protein: potential antivirus drug development for COVID-19.
Huang Y; Yang C; Xu XF; Xu W; Liu SW
Acta Pharmacol Sin; 2020 Sep; 41(9):1141-1149. PubMed ID: 32747721
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of SARS-CoV-2 wild-type (Wuhan-Hu-1) and Delta (B.1.617.2) strains by marine sulfated glycans.
Dwivedi R; Sharma P; Farrag M; Kim SB; Fassero LA; Tandon R; Pomin VH
Glycobiology; 2022 Sep; 32(10):849-854. PubMed ID: 35788318
[TBL] [Abstract][Full Text] [Related]
16. Application prospect of polysaccharides in the development of anti-novel coronavirus drugs and vaccines.
Chen X; Han W; Wang G; Zhao X
Int J Biol Macromol; 2020 Dec; 164():331-343. PubMed ID: 32679328
[TBL] [Abstract][Full Text] [Related]
17. Algae-Derived Bioactive Molecules for the Potential Treatment of SARS-CoV-2.
Alam MA; Parra-Saldivar R; Bilal M; Afroze CA; Ahmed MN; Iqbal HMN; Xu J
Molecules; 2021 Apr; 26(8):. PubMed ID: 33917694
[TBL] [Abstract][Full Text] [Related]
18. Iota-Carrageenan Inhibits Replication of SARS-CoV-2 and the Respective Variants of Concern Alpha, Beta, Gamma and Delta.
Fröba M; Große M; Setz C; Rauch P; Auth J; Spanaus L; Münch J; Ruetalo N; Schindler M; Morokutti-Kurz M; Graf P; Prieschl-Grassauer E; Grassauer A; Schubert U
Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34947999
[TBL] [Abstract][Full Text] [Related]
19. Design of Potent Membrane Fusion Inhibitors against SARS-CoV-2, an Emerging Coronavirus with High Fusogenic Activity.
Zhu Y; Yu D; Yan H; Chong H; He Y
J Virol; 2020 Jul; 94(14):. PubMed ID: 32376627
[TBL] [Abstract][Full Text] [Related]
20. Synergistic antiviral effect of hydroxychloroquine and azithromycin in combination against SARS-CoV-2: What molecular dynamics studies of virus-host interactions reveal.
Fantini J; Chahinian H; Yahi N
Int J Antimicrob Agents; 2020 Aug; 56(2):106020. PubMed ID: 32405156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
